Ardent Health Shareholders Can Join Securities Fraud Class Action by March 9
Pomerantz LLP sues Ardent Health for securities fraud over November 2025 disclosures revealing $43M revenue decrease and $57.5M EBITDA cut, causing 33.81% stock decline. Shareholders can join by March 9.
ARDTsecurities fraudclass action lawsuit